Fore Biotherapeutics Funding & Investors

Fore Biotherapeutics is a precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics.

Total Amount Raised: $166,500,000

Series C
$57,000,000
Sep 20, 2020
Series C Investors
HBM Healthcare Investments
Novartis Venture Fund
Sr One
Wellington Management
Cormorant Asset Management
OrbiMed Advisors
Pontifax
Series Unknown
$6,000,000
Apr 29, 2018
Series Unknown Investors
Bio Capital Impact Fund
3B Future Health Fund
SICAR
Windham Venture Partners
Series D
$75,000,000
Aug 22, 2023
Series D Investors
Novartis Venture Fund
3B Future Health Fund
Sr One
Wellington Management
Samsung Securities Co.
Cormorant Asset Management
HBM Partners
OrbiMed Advisors
Medicxi
Series Unknown
$2,500,000
Jun 21, 2016
Series Unknown Investors
OrbiMed Advisors
Series Unknown
$10,000,000
Dec 22, 2015
Series Unknown Investors
INTERCURE
Seed
$8,000,000
Jun 30, 2014
Seed
$8,000,000
Jun 30, 2013

Funding info provided by Diffbot.